Loading... Please wait... Loading... Please wait...
ESTIMATED
(AS OF MARCH 31)
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 04/09/2024 | Q2 2024 | -$0.06 | $145,000 | 01/12/2024 | Q1 2024 | -$0.13 | $151,278 | 11/20/2023 | Q4 2023 | -$0.19 | $-3,433 | 07/14/2023 | Q3 2023 | -$0.37 | $93,150 | 04/14/2023 | Q2 2023 | -$0.22 | $35,015 | 01/17/2023 | Q1 2023 | -$0.30 | $101,476 | 11/25/2022 | Q4 2022 | -$0.25 | $111,150 | 07/14/2022 | Q3 2022 | -$0.40 | $99,717 | 04/11/2022 | Q2 2022 | -$0.24 | $30,650 | 01/14/2022 | Q1 2022 | -$0.35 | $13,880 | 11/26/2021 | Q4 2021 | -$0.23 | $31,021 | 07/15/2021 | Q3 2021 | -$0.50 | $204,055 | 04/14/2021 | Q2 2021 | $0.09 | $192,006 | 01/14/2021 | Q1 2021 | -$0.23 | $295,656 | 10/14/2020 | Q4 2020 | -$0.14 | $133,739 | 06/30/2020 | Q3 2020 | -$0.49 | $81,423 | 04/02/2020 | Q2 2020 | -$0.36 | $107,299 | 01/08/2020 | Q1 2020 | -$0.34 | $62,082 | 11/14/2019 | Q4 2019 | -$0.40 | $125,121 | 07/08/2019 | Q3 2019 | -$0.44 | $59,931 |
|---|
A. Lexaria Bioscience Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 30th, 2023 based off last year's report dates.
A. The conference call for Lexaria Bioscience Corp.'s latest earnings report can be listened to online.
A. The conference call transcript for Lexaria Bioscience Corp.'s latest earnings report can be read online.
A. Lexaria Bioscience Corp. (NASDAQ:LEXXW) has a recorded annual revenue of $226,208.
A. Lexaria Bioscience Corp. (NASDAQ:LEXXW) has a recorded net income of $226,208. Lexaria Bioscience Corp. has generated $-1.01 earnings per share over the last four quarters.
A. Lexaria Bioscience Corp. (NASDAQ:LEXXW) has a price-to-earnings ratio of -5.26 and price/earnings-to-growth ratio is -0.25.
